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Editorial

Percutaneous Intervention and In-Hospital Mortality: A
Contemporary Risk-Prediction Model
Risk-prediction models play a pivotal role in informing clinical decisions both in ensuring and measuring quality of care
and in helping payers determine payments to healthcare institutions. The CathPCI registry is a national surveillance system,
designed to assess characteristics and outcomes of patients
undergoing coronary angiography and percutaneous intervention (PCI) in the United States.1 The CathPCI registry collects
data from >1,600 hospitals in the United States. In 2013,
Brennan et al. performed an analysis of the CathPCI registry
and reported an overall in-hospital mortality of 1.4% and
developed three scoring models (pre cath, full model, and a
simplified bedside model) to predict mortality in these
patients.2 However, given concerns that this existing model
does not perform well in extremes of risk as well as for lowervolume hospitals, a newer, more contemporary model was
needed.3 An additional driver for more accurate risk prediction
is the public reporting of PCI outcomes and use of these models to determine payment to hospitals. Several reports have
indicated that while, theoretically, this may allow for improved
standardization of care and appropriate patient selection, there
is an increasing concern that these drive risk-averse behavior
among interventional cardiologists, wherein patients who are
appropriate for coronary angiography and revascularization
may not undergo these procedures.4,5 For example, in an analysis of the SHOCK registry, patients with acute myocardial
infarction and cardiogenic shock from New York (a state that
has mandated public reporting of PCI outcomes) had a higher
adjusted mortality and were less likely to undergo angiography
and PCI. They also were likely to wait significantly longer to
undergo coronary artery bypass grafting than their non-New
York counterparts.5
Given these concerns, Castro-Dominguez et al. studied
706,263 PCIs between July 2018 and June 2019 using the
CathPCI registry.3 They used version five of the data collection form (launched in 2018), which included new variables
such as frailty, cardiovascular instability, level of consciousness after cardiac arrest, and decision for PCI with surgical
consult. The study population was allocated randomly into a
model-development cohort (70% of total) and a validation
cohort (30% of total). The authors created a new ordinal
https://doi.org/10.1053/j.jvca.2021.08.102
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variable to reflect clinical severity. This included six mutually
exclusive categories: (1) salvage PCI or refractory shock, (2)
cardiogenic shock (not refractory) without salvage, (3) cardiovascular instability (CVI) (includes hemodynamic instability,
acute heart failure symptoms, and ventricular arrhythmia in
the absence of shock) without salvage, (4) emergency PCI
without shock or CVI, (5) urgent PCI without shock or CVI,
and (6) elective PCI without shock or CVI. The National Cardiovascular Database Registry established a work group of
volunteers to oversee model development and to provide input
on variable selection. Candidate variables were screened and
selected based on clinical relevance and association with mortality based on prior research. Final variable selection was
based on persistence of statistical significance in more than
700 permutations of the 1,000 bootstrap samples randomly
created in the derivation set.6 Thereafter, a multivariate linear
regression model was created linking mortality to the selected
variables. Three models were created (similar to the 2013 risk
assessment score).2 These included (1) a full model that
included all the candidate variable, (2) a pre-cath model that
excluded angiographic data, and (3) a simplified bedside risk
score (which included variables that explained >90% of the
model).
The mean age of patients in the study was 66 years; 31%
were women, and 85% of patients were white. Elective procedures represented 39% of the population. The overall mortality
was 1.9% (similar in both development and validation
cohorts). The mortality ranged from 0.2% for elective procedures without CVI or shock to 62% in salvage PCI or refractory shock cases. The full model included 21 unique variables
of which the following are new to the 2021 model: unresponsiveness after cardiac arrest, severe frailty (in patients without
cardiac arrest, shock, or salvage), moderate or more severe
aortic stenosis, and surgery not recommended. The bedside
risk score model contains the variables (age, chronic kidney
disease, clinical instability, cardiac arrest) that had the strongest association with mortality and that in combination
explained >90% of the risk model (Fig 1).3 This has changed
significantly from the prior bedside model (2013), which
included ST-elevation myocardial infarction, age, body mass
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Fig 1. The bedside risk score. CKD, chronic kidney disease; CVI, cardiovascular instability; DM, diabetes mellitus; LAD, left anterior descending; LVEF, left
ventricular ejection fraction; PCI, percutaneous intervention; RCA, right coronary artery; STEMI, ST-segment elevation myocardial infarction.

index, cerebrovascular disease, peripheral arterial disease,
chronic lung disease, prior PCI, diabetes, glomerular filtration
rate, ejection fraction, cardiogenic shock/PCI status, New
York Heart Association class, and cardiac arrest.2 Traditional
predictors of risk, such as ejection fraction, and comorbidities,
such as diabetes, lung disease and peripheral arterial disease,
have lost their place in the new model. It is possible that this is
due to the technical and technologic advancements over the
years. However, as the overall mortality following PCI
remains unchanged, it is more likely that it reflects the higher
discriminatory power of variables such as clinical instability.
For example, for a relatively young patient with clinical instability (50-year-old with cardiogenic shock following ST-segment elevation myocardial infarction), the model reclassifies
the patient to a higher-risk subgroup (Fig 1). This is important
for quality control, payments to hospitals, and public reporting
of data, as it appropriately reflects the risk profile of patients
with a high degree of clinical instability. To conclude, new
variables that were associated with higher in-hospital mortality
included pre-PCI clinical instability, unresponsiveness after
cardiac arrest, moderate aortic stenosis, inoperable patients,
and patients with high frailty scores. Also, for the first time,
emphasis on a multidisciplinary heart team approach was
noted and will be included in the overall risk modeling. One of
the key limitations of this dataset was that participation in the
registry was voluntary and although data were included from
>90% of US hospitals, it may not be reflective of smaller hospitals or non-US practices.3 Regardless, the new model does
have excellent discrimination in the derivation and validation
cohorts and, therefore, is one that likely will be used routinely
in estimating risk for patients undergoing PCI and will aid in
standardizing risk assessment for payers, hospitals, and
physicians.
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